Replies to post #150 on Savient Pharmaceuticals Inc (fka SVNTQ)

[surf1944]

7:33AM Savient Pharma names rheumatology veteran Kenneth Bahrt CMO; effective August 1st (SVNT) 7.45 : Bahrt joins Savient from Genentech, recently acquired by Roche (RHHBY) where he served as Therapeutic Area Head for US Medical Affairs leading the medical affairs team for four marketed biological products and serving as the US medical lead on their Rheumatology Global Franchise Team.

[papaul]

Hello Surf - I'm thinking about a re-entry on this one but all the analysts are setting on "SELL" recommendations.

What do you think ??

papaul